Using restriction endonuclease analysis and a human growth hormone cDNA probe, we have found a Chinese family with a human growth hormone gene deletion. Two affected sibs are homozygous for a deletion of approximately 7
family with two affected girls who are homozygous for a deletion of the hGH-N gene. This is the first case of familial isolated growth hormone deficiency type IA with hGH-N gene deletion reported in the Chinese population.
Materials and methods

SUBJECTS
A family with eight members was studied. Two female sibs have isolated growth hormone deficiency as shown in the High molecular weight DNA was prepared from peripheral blood leucocytes according to standard procedures. Briefly, leucocytes were harvested from 5 ml heparinised whole blood with dextran, lysed with buffer containing SDS, and digested with proteinase K. DNA was extracted with phenol and chloroform. The alcohol precipitated crude DNA was digested with RNase and proteinase K again and re-extracted with phenol, chloroform, and subjected to alcohol precipitation (E 260 nm/E 280 nm of the DNA= 1.6-1.8). The DNA was more than 50 kb as checked by agarose gel electrophoresis.
hGH PROBE PREPARATION
The recombinant plasmid chGH 800/pBR 322 con- were heterozygotes, with a normal allele containing the hGH-N gene and an abnormal one without it. Therefore, the patients have inherited an abnormal chromosome 17 from each of 'their heterozygous parents. They are homozygous for a deletion of approximately 7.1 kb of DNA, which contains the hGH-N gene. The HindIII patterns of DNA from the grandfathers were identical to normal ones. This suggests that the grandfathers are normal homozygotes (fig 4) . The genotypes and phenotypes of the family members are compatible with an autosomal recessive mode of inheritance. We also found that the hybridisation patterns of DNA from normal chorionic villi were identical to those from normal peripheral blood leucocytes (figs 5 and 6).
Discussion
There are three modes of inheritance in isolated growth hormone deficiency (IGHD), namely auto-somal recessive (type I), autosomal dominant (type II), and X linked recessive (type III). Phillips et at' studied the genomic DNA structure from patients defined as IGHD type IA by Illig et alIl using Southern blotting. They found that the patients were homozygous for a deletion of 6.7 kb, which included the gene encoding for normal hGH. Our Chinese patients had an average weight and normal length at birth, but they showed extreme growth retardation during infancy and childhood. The older sister is now 112 years old and the younger one is 8 years 2 months and their height is the same as that of normal 1 or 2 year olds. Our patients also had the typical facial appearance characteristic of IGHD type IA. The results of Southern blotting showed that the two affected girls had a deletion of the hGH-N gene, but other genes of the growth hormone gene cluster on chromosome 17 are still retained. Although the patients have not received hGH treatment yet, they have many characteristics of IGHD IA and may be considered as IGHD type IA.
So far, 11 families have been reported to have IGHD type IA associated with a deletion of the hGH-N gene. Consanguinity was present in nine of these, including our Chinese family.
There are differences in the location and the extent of the deletion in different IGHD IA families reported. For example, the patients reported from the Swiss, Argentinian, Austrian, and Japanese families were homozygous for a DNA deletion of 6.7 kb,"7 patients from Iraqi, Yemenite, and Iranian families for 7.5 kb,8 and Italian patients for 7.6 kb.9 Our patients were homozygous for a deletion of about 7.1 kb. A recent paper described a double deletion in the human GH gene cluster and a total of about 40 kb DNA, containing the hGH-N, hCS-A, hCS-B, and hGH-V genes, was absent.'0 These data suggest that the breakpoints in the GH gene cluster are different in the patients reported and the molecular mechanisms of hGH-N gene deletion are also different. It is an interesting problem for further study.
Another intriguing phenomenon is that IGHD IA patients from quite different origins may possess the same length of DNA deletion. For example, the Swiss, Argentinian, Austrian, and Japanese patients all had a deletion of 6.7 kb DNA containing hGH-N, while the Italian, Iraqi, Yemenite, and Iranian patients all had a deletion of 7.5 kb or 7.6 kb. This implies that there may be some common sequences in specific sites in the intergenic region on both sides of the hGH-N gene on the abnormal chromosome 17, and these sequences possibly are not present in the DNA of the normal hGH/hCS gene cluster. Mutation in these specific sites may make them accessible to some special proteins, like recombinases, or an unknown mechanism, which results in a deletion of the same length of DNA. Therefore, analysis of the sequences around the breakpoints will help us to understand the molecular basis of hGH-N gene deletion.
